BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 27356823)

  • 21. A comparison of FibroMeter™ NAFLD Score, NAFLD fibrosis score, and transient elastography as noninvasive diagnostic tools for hepatic fibrosis in patients with biopsy-proven non-alcoholic fatty liver disease.
    Aykut UE; Akyuz U; Yesil A; Eren F; Gerin F; Ergelen R; Celikel CA; Yilmaz Y
    Scand J Gastroenterol; 2014 Nov; 49(11):1343-8. PubMed ID: 25259621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association Between Obesity and Discordance in Fibrosis Stage Determination by Magnetic Resonance vs Transient Elastography in Patients With Nonalcoholic Liver Disease.
    Caussy C; Chen J; Alquiraish MH; Cepin S; Nguyen P; Hernandez C; Yin M; Bettencourt R; Cachay ER; Jayakumar S; Fortney L; Hooker J; Sy E; Valasek MA; Rizo E; Richards L; Brenner DA; Sirlin CB; Ehman RL; Loomba R
    Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1974-1982.e7. PubMed ID: 29104128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis.
    Singh S; Venkatesh SK; Loomba R; Wang Z; Sirlin C; Chen J; Yin M; Miller FH; Low RN; Hassanein T; Godfrey EM; Asbach P; Murad MH; Lomas DJ; Talwalkar JA; Ehman RL
    Eur Radiol; 2016 May; 26(5):1431-40. PubMed ID: 26314479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD.
    Tapper EB; Loomba R
    Nat Rev Gastroenterol Hepatol; 2018 May; 15(5):274-282. PubMed ID: 29463906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. US Time-Harmonic Elastography: Detection of Liver Fibrosis in Adolescents with Extreme Obesity with Nonalcoholic Fatty Liver Disease.
    Hudert CA; Tzschätzsch H; Guo J; Rudolph B; Bläker H; Loddenkemper C; Luck W; Müller HP; Baumgart DC; Hamm B; Braun J; Holzhütter HG; Wiegand S; Sack I
    Radiology; 2018 Jul; 288(1):99-106. PubMed ID: 29762096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of Three-Dimensional Magnetic Resonance Elastography in the Diagnosis of Nonalcoholic Steatohepatitis in Obese Patients Undergoing Bariatric Surgery.
    Allen AM; Shah VH; Therneau TM; Venkatesh SK; Mounajjed T; Larson JJ; Mara KC; Schulte PJ; Kellogg TA; Kendrick ML; McKenzie TJ; Greiner SM; Li J; Glaser KJ; Wells ML; Chen J; Ehman RL; Yin M
    Hepatology; 2020 Feb; 71(2):510-521. PubMed ID: 30582669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic resonance elastography in staging liver fibrosis in non-alcoholic fatty liver disease: a pooled analysis of the diagnostic accuracy.
    Liang Y; Li D
    BMC Gastroenterol; 2020 Apr; 20(1):89. PubMed ID: 32252641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study.
    Loomba R; Wolfson T; Ang B; Hooker J; Behling C; Peterson M; Valasek M; Lin G; Brenner D; Gamst A; Ehman R; Sirlin C
    Hepatology; 2014 Dec; 60(6):1920-8. PubMed ID: 25103310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transient and 2-Dimensional Shear-Wave Elastography Provide Comparable Assessment of Alcoholic Liver Fibrosis and Cirrhosis.
    Thiele M; Detlefsen S; Sevelsted Møller L; Madsen BS; Fuglsang Hansen J; Fialla AD; Trebicka J; Krag A
    Gastroenterology; 2016 Jan; 150(1):123-33. PubMed ID: 26435270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future.
    Yu JH; Lee HA; Kim SU
    Clin Mol Hepatol; 2023 Feb; 29(Suppl):S136-S149. PubMed ID: 36503205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic usefulness of FibroMeter VCTE for hepatic fibrosis in patients with nonalcoholic fatty liver disease.
    Dincses E; Yilmaz Y
    Eur J Gastroenterol Hepatol; 2015 Oct; 27(10):1149-53. PubMed ID: 26049712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of imaging-based biomarkers in NAFLD: Recent advances in clinical application and future research directions.
    Loomba R
    J Hepatol; 2018 Feb; 68(2):296-304. PubMed ID: 29203392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accuracy of the Enhanced Liver Fibrosis Test vs FibroTest, Elastography, and Indirect Markers in Detection of Advanced Fibrosis in Patients With Alcoholic Liver Disease.
    Thiele M; Madsen BS; Hansen JF; Detlefsen S; Antonsen S; Krag A
    Gastroenterology; 2018 Apr; 154(5):1369-1379. PubMed ID: 29317276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Magnetic Resonance Elastography for the Evaluation of Liver Fibrosis in Chronic Hepatitis B and C by Using Both Gradient-Recalled Echo and Spin-Echo Echo Planar Imaging: A Prospective Study.
    Shi Y; Xia F; Li QJ; Li JH; Yu B; Li Y; An H; Glaser KJ; Tao S; Ehman RL; Guo QY
    Am J Gastroenterol; 2016 Jun; 111(6):823-33. PubMed ID: 26977760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of liver fibrosis with 2-D shear wave elastography in comparison to transient elastography and acoustic radiation force impulse imaging in patients with chronic liver disease.
    Gerber L; Kasper D; Fitting D; Knop V; Vermehren A; Sprinzl K; Hansmann ML; Herrmann E; Bojunga J; Albert J; Sarrazin C; Zeuzem S; Friedrich-Rust M
    Ultrasound Med Biol; 2015 Sep; 41(9):2350-9. PubMed ID: 26116161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-invasive assessment of fibrosis and steatosis in pediatric non-alcoholic fatty liver disease.
    Chen BR; Pan CQ
    Clin Res Hepatol Gastroenterol; 2022 Jan; 46(1):101755. PubMed ID: 34311134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance.
    Stål P
    World J Gastroenterol; 2015 Oct; 21(39):11077-87. PubMed ID: 26494963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost Effectiveness of Different Strategies for Detecting Cirrhosis in Patients With Nonalcoholic Fatty Liver Disease Based on United States Health Care System.
    Vilar-Gomez E; Lou Z; Kong N; Vuppalanchi R; Imperiale TF; Chalasani N
    Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2305-2314.e12. PubMed ID: 32289535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetic resonance elastography measured shear stiffness as a biomarker of fibrosis in pediatric nonalcoholic fatty liver disease.
    Schwimmer JB; Behling C; Angeles JE; Paiz M; Durelle J; Africa J; Newton KP; Brunt EM; Lavine JE; Abrams SH; Masand P; Krishnamurthy R; Wong K; Ehman RL; Yin M; Glaser KJ; Dzyubak B; Wolfson T; Gamst AC; Hooker J; Haufe W; Schlein A; Hamilton G; Middleton MS; Sirlin CB
    Hepatology; 2017 Nov; 66(5):1474-1485. PubMed ID: 28493388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic resonance elastography identifies fibrosis in adults with alpha-1 antitrypsin deficiency liver disease: a prospective study.
    Kim RG; Nguyen P; Bettencourt R; Dulai PS; Haufe W; Hooker J; Minocha J; Valasek MA; Aryafar H; Brenner DA; Sirlin CB; Loomba R
    Aliment Pharmacol Ther; 2016 Aug; 44(3):287-99. PubMed ID: 27279429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.